AWH: Vermillion Market Cap to Earnings

Aspira Women's Health, Inc. - graphic logo of issuer AWH

Aspira Women's Health is implementing advanced OvaSuite bioinformatic systems for cancer detection, and the market dynamics reflected in the quotes on GURU.Markets capture the -0.20 indicator. The company is developing a digital diagnostic environment where cloud-based data analysis helps medical professionals promptly identify pathologies. However, financial growth is constrained by a dependence on US insurance reimbursement terms, which limits the company's pricing power.

Aspira Women's Health Inc. (AWH) P/E Multiple: for the period 07/04/2022 - 04/19/2025

Comprehensive metric breakdowns and analytics for Aspira Women's Health Inc (AWH)

- stock quotes and analyst forecast:
- market capitalization information:
Comprehensive company analysis:Aspira Women's Health
Manufactured product of Vermillion

Aspira Women's Health operates in the protected oncology diagnostics segment characterized by inelastic demand. This ratio measures the market value of a single unit of net profit, determining the current control premium for the business. By analyzing the current market P/E of Aspira Women's Health, an investor assesses whether growth expectations are justified relative to actual earnings. The indicator's trend reflects the balance between market optimism and fundamental inflation resistance. Long-term consensus establishes the asset's fair value price range.

Analysis of competing companies